Artículos por temáticas

The functional roles of retromer in Parkinson's disease.

Cui Y, Yang Z, Teasdale RD.

FEBS Lett. 2017 Dec 6. doi: 10.1002/1873-3468.12931. [Epub ahead of print] Review.

Glaucocalyxin B Alleviates Lipopolysaccharide-Induced Parkinson's Disease by Inhibiting TLR/NF-κB and Activating Nrf2/HO-1 Pathway.

Xu W, Zheng D, Liu Y, Li J, Yang L, Shang X.

Cell Physiol Biochem. 2017 Dec 12;44(6):2091-2104. doi: 10.1159/000485947. [Epub ahead of print]

The serotonergic system in Parkinson's patients with dyskinesia: evidence from imaging studies.

Pagano G, Niccolini F, Politis M.

J Neural Transm (Vienna). 2017 Dec 20. doi: 10.1007/s00702-017-1823-7. [Epub ahead of print] Review.

Comorbid Conditions in Parkinson's Disease: A Population-Based Study of Statewide Parkinson's Disease Registry.

Xu K, Alnaji N, Zhao J, Bertoni JM, Chen LW, Bhatti D, Qu M.

Neuroepidemiology. 2017 Dec 22;50(1-2):7-17. doi: 10.1159/000484410. [Epub ahead of print]

Empirical Wavelet Transform Based Features for Classification of Parkinson's Disease Severity.

Oung QW, Muthusamy H, Basah SN, Lee H, Vijean V.

J Med Syst. 2017 Dec 29;42(2):29. doi: 10.1007/s10916-017-0877-2.

PBPK/PD assessment for Parkinson's disease risk posed by airborne pesticide paraquat exposure.

Cheng YH, Chou WC, Yang YF, Huang CW, How CM, Chen SC, Chen WY, Hsieh NH, Lin YJ, You SH, Liao CM.

Environ Sci Pollut Res Int. 2017 Dec 5. doi: 10.1007/s11356-017-0875-4. [Epub ahead of print]

Neuronal inhibition and synaptic plasticity of basal ganglia neurons in Parkinson's disease.

Milosevic L, Kalia SK, Hodaie M, Lozano AM, Fasano A, Popovic MR, Hutchison WD.

Brain. 2017 Dec 11. doi: 10.1093/brain/awx296. [Epub ahead of print]

The Five Dimensions of Parkinson's Disease Genetic Risk.

Coetzee GA, Pierce S.

J Parkinsons Dis. 2017 Dec 15. doi: 10.3233/JPD-171256. [Epub ahead of print]

Mini-review on initiatives to interfere with the propagation and clearance of alpha-synuclein in Parkinson's disease.

Chan DKY, Xu YH, Chan LKM, Braidy N, Mellick GD.

Transl Neurodegener. 2017 Dec 20;6:33. doi: 10.1186/s40035-017-0104-6. eCollection 2017. Review.

Subthalamic deep brain stimulation and trunk posture in Parkinson's disease.

Artusi CA, Zibetti M, Romagnolo A, Rizzone MG, Merola A, Lopiano L.

Acta Neurol Scand. 2017 Dec 29. doi: 10.1111/ane.12889. [Epub ahead of print]

Connecting Gaucher and Parkinson Disease: Considerations for Clinical and Research Genetic Counseling Settings.

Cook L, Schulze J.

J Genet Couns. 2017 Dec;26(6):1165-1172. doi: 10.1007/s10897-017-0123-6. Epub 2017 Jun 30.

Principles and approaches to the treatment of immune-mediated movement disorders.

Mohammad SS, Dale RC.

Eur J Paediatr Neurol. 2017 Dec 19. pii: S1090-3798(17)31734-8. doi: 10.1016/j.ejpn.2017.11.010. [Epub ahead of print] Review.

Introduction to the Special Issue on Clinical Neuropsychology of Movement Disorders.

Tröster AI.

Arch Clin Neuropsychol. 2017 Nov 1;32(7):767-768. doi: 10.1093/arclin/acx087.

ACR-ACNM Practice Parameter for the Performance of Dopamine Transporter (DaT) Single Photon Emission Computed Tomography (SPECT) Imaging for Movement Disorders.

Subramaniam RM, Frey KA, Hunt CH, Mercier GA Jr, Solnes LB, Colletti PM, Lu Y, Savir-Baruch B, Williams HT.

Clin Nucl Med. 2017 Sep 15. doi: 10.1097/RLU.0000000000001815. [Epub ahead of print]

A Comprehensive Approach to Deep Brain Stimulation for Movement Disorders.

Akbar U, Asaad WF.

R I Med J (2013). 2017 Jun 1;100(6):30-33.